Pacer Advisors Inc. purchased a new position in Fresenius Medical Care Corporation (NYSE:FMS) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 3,711 shares of the company’s stock, valued at approximately $179,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of FMS. Bank of New York Mellon Corp grew its position in Fresenius Medical Care Corporation by 27.9% in the 1st quarter. Bank of New York Mellon Corp now owns 49,250 shares of the company’s stock worth $2,075,000 after purchasing an additional 10,751 shares during the last quarter. Comerica Bank boosted its position in shares of Fresenius Medical Care Corporation by 2.8% during the 1st quarter. Comerica Bank now owns 45,475 shares of the company’s stock valued at $2,029,000 after acquiring an additional 1,236 shares in the last quarter. Eagle Asset Management Inc. boosted its position in shares of Fresenius Medical Care Corporation by 18.2% during the 1st quarter. Eagle Asset Management Inc. now owns 8,146 shares of the company’s stock valued at $343,000 after acquiring an additional 1,254 shares in the last quarter. Parametric Portfolio Associates LLC boosted its position in shares of Fresenius Medical Care Corporation by 21.4% during the 1st quarter. Parametric Portfolio Associates LLC now owns 369,566 shares of the company’s stock valued at $15,570,000 after acquiring an additional 65,196 shares in the last quarter. Finally, Stevens Capital Management LP acquired a new stake in shares of Fresenius Medical Care Corporation during the 1st quarter valued at about $337,000. Institutional investors own 2.61% of the company’s stock.

Fresenius Medical Care Corporation (FMS) opened at 48.75 on Monday. The stock has a 50 day moving average of $46.93 and a 200 day moving average of $45.84. The company has a market capitalization of $29.92 billion, a price-to-earnings ratio of 21.02 and a beta of 0.48. Fresenius Medical Care Corporation has a 12 month low of $38.05 and a 12 month high of $50.22.

Fresenius Medical Care Corporation (NYSE:FMS) last announced its quarterly earnings data on Tuesday, August 1st. The company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.53 by ($0.05). Fresenius Medical Care Corporation had a net margin of 7.06% and a return on equity of 11.57%. The firm had revenue of $4.47 billion during the quarter, compared to the consensus estimate of $5.20 billion. During the same quarter in the prior year, the firm posted $0.96 earnings per share. The company’s revenue was up 11.1% on a year-over-year basis. Equities analysts anticipate that Fresenius Medical Care Corporation will post $2.35 EPS for the current fiscal year.

A number of equities analysts have commented on the stock. Royal Bank Of Canada restated a “hold” rating and issued a $44.00 price target on shares of Fresenius Medical Care Corporation in a research report on Wednesday, September 13th. Zacks Investment Research downgraded shares of Fresenius Medical Care Corporation from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 16th. DZ Bank AG reaffirmed a “buy” rating on shares of Fresenius Medical Care Corporation in a research note on Monday, August 7th. BidaskClub downgraded shares of Fresenius Medical Care Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Finally, UBS AG reissued a “sell” rating on shares of Fresenius Medical Care Corporation in a research note on Tuesday, July 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $48.67.

WARNING: “Pacer Advisors Inc. Invests $179,000 in Fresenius Medical Care Corporation (FMS) Stock” was originally published by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was stolen and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be accessed at https://www.dailypolitical.com/2017/09/18/pacer-advisors-inc-invests-179000-in-fresenius-medical-care-corporation-fms-stock.html.

Fresenius Medical Care Corporation Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

Institutional Ownership by Quarter for Fresenius Medical Care Corporation (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.